CD33 and urinary bladder neoplasm: The representative IHC stain of Siglec-15 in bladder tumors was shown in Fig. 2B. Consistent with its well-recognized immune suppressor role, we also noticed that relatively low CD4 and high CD33/204 abundance associating with Siglec-15 positivity (Fig. S1).